background: Clusterin, a heterodimeric glycoprotein found at several sites in the human male reproductive tract, could be a marker of morphologically abnormal spermatozoa, while TUNEL positivity indicates DNA fragmentation. Metabolic disorders such as diabetes mellitus and obesity may compromise sperm quality and fertility of men; however, little evidence specifically links hypertension with the impairment of male reproductive function.
Introduction
High blood pressure (hypertension) is a well-established risk factor promoting micro-and macro-vascular diseases, as well as target-organ injury or failure. Hypertension represents a major symptom of the metabolic syndrome (Kasturi et al., 2008) . Several studies, which examined the effects of hypertension on the male reproductive system, demonstrated an inverse relationship between blood pressure and total serum testosterone (Khaw and Barret-Connor, 1988; Fogari et al., 2002) , free testosterone (Hughes et al., 1989; Phillips et al., 1993; Svartberg et al., 2004) and sex hormone-binding globulin (Svartberg et al., 2004) . Nevertheless, there is little evidence to specifically link hypertension with the impairment of male reproductive function.
With the aim of evaluating potential relationships between high blood pressure and male fertility, we studied the quality of ejaculated spermatozoa in a group of 25 subjects affected by hypertension and an equivalent number of healthy subjects with normal blood pressure. In addition to the conventional seminal fluid examination (World Health Organization, 1999) , we evaluated the quality of ejaculated spermatozoa by measuring: (i) the presence and the distribution of clusterin antigen in the sperm by immunofluorescence and cytometric analyses and (ii) sperm DNA fragmentation by the TUNEL assay. Clusterin (also referred to as apo-lipoprotein J) is an 80-kDa heterodimeric glycoprotein consisting of a and b chains produced by the somatic cells in the human male reproductive tract (O'Bryan et al., 1994a; Tenniswood et al., 1998) and typically localized to the acrosomal region in the normal spermatozoa (O'Bryan et al., 1994b) . Clusterin is a chaperone-like lipid carrier involved in fertility-related processes such as the prevention of oxidative damage (Trougakos and Gonos, 2002) and complement-mediated sperm lysis (Jenne and Tschopp, 1989) , agglutination of spermatozoa (Carlsson et al., 2004) , membrane protection and membrane remodeling during sperm maturation (Griffiths et al., 2009) . Recently, this multi-functional protein has been demonstrated to be part of the Eppin (epididymal protease inhibitor) protein complex (EPC), originated from the Sertoli and epididymal epithelial cells that coats the surface of human ejaculated spermatozoa (Wang et al., 2007) . EPC is composed of three proteins, semenogelin-1, clusterin and lactotransferrin bound to the Eppin and is thought to fulfill a variety of fertilization-related functions, such as antimicrobial activity (Yenugu et al., 2004) , ejaculate sperm protection, motility regulation and gain of competence for acrosome reaction (Paasch et al., 2011) . Conversely, an intense and diffusely expressed surface heterodimeric clusterin coating has been observed in morphologically abnormal and in agglutinated spermatozoa present in the human semen and it has been proposed as a good marker for poor sperm quality (O'Bryan et al., 1994a,b; Muciaccia et al., 2010) . In the same direction, flow cytometric analysis in the bull semen has revealed that highly clusterin-positive spermatozoa exhibit abnormal morphology and that their percentage is inversely related to the semen fertilizing ability (Ibrahim et al., 2000) . The TUNEL assay is largely used to detect the incidence of DNA fragmentation in human spermatozoa, not necessarily associated with cell death, which is not revealed by routine semen analysis (Sakkas et al., 1999; Sergerie et al., 2005; Erenpreiss et al., 2006; Muratori et al., 2006) .
Our data demonstrated that, even in the absence of significant differences in the semen quality following conventional analysis, the percentage of spermatozoa revealed by intensive labeling with clusterin antibody with an abnormal morphology was statistically higher in the subjects affected by hypertension with respect to controls. Statistical analyses clearly demonstrated that the observed intensive sperm labeling with clusterin in the hypertensive subject was not correlated with age nor with sperm cell mortality, whereas a highly significant correlation was observed with sperm DNA fragmentation as revealed by TUNEL.
Methods
We studied a cohort of 25 subjects (from 24 to 60 years old) affected by hypertension of unknown origin not associated with co-morbid disorders such as diabetes mellitus and obesity or other pathologic conditions potentially affecting male fertility. The blood pressure readings in untreated hypertensive subjects (n ¼ 4) showed diastolic levels ranging between 100 and 120 mmHg and systolic levels ranging between 150 and 170 mmHg. These subjects suffered from untreated hypertension for at least 2 years. The blood pressure readings from drug-treated hypertensive subjects (n ¼ 21) indicated diastolic levels of 80 mmHg and systolic levels ranging between 120 and 130 mmHg. These hypertensive subjects were in therapy for a period ranging from 5 to 10 years. Anti-hypertensive agents used were either one or two of these classes of drugs: (i) angiotensin-converting enzyme inhibitors; (ii) calcium channel blockers; (iii) angiotensin II (AII) receptor antagonist; (iv) b-blocking agents and (v) a2 receptor agonists.
A cohort of 25 subjects (from 22 to 50 years old), not medically or surgically treated in the 3 months prior to the study, with normal blood pressure, attending the Seminology Laboratory-Sperm Bank of 'Sapienza' University of Rome for premarital control, has been studied as the reference group. All subjects underwent a complete physical, andrological examination and semen analysis. No diseases were observed on general physical examination. All subjects showed a normal male phenotype with a normal body, axillary and pubic hair distribution. All had gonads descended normally at birth, and testicular volumes were in the normal range.
This study was approved by the Institutional Review Board of our University Hospital. Written consent for the use of sperm for research was obtained from the patients according to the guidelines of the Sapienza University of Rome Committee for research on human projects.
Seminal fluid examination
All the procedures were performed as suggested by the World Health Organization (WHO) Manual (World Health Organization, 1999) . Semen samples were collected by masturbation in the Seminology Laboratory facilities, after 3 -5 days of abstinence. Samples were allowed to liquefy at 378C for 60 min prior to being analyzed. The following variables were considered: ejaculate volume (ml), sperm concentration (n × 10 6 /ml), total sperm count (n × 10 6 /ejaculate), forward motility (%), morphology (% of abnormal forms) and vitality (%).
The classification methodology used to analyze the sperm morphology was that suggested by WHO Manual (World Health Organization, 1992) . Seminal plasma was removed by centrifugation at 500g for 10 min. The pellet was washed in phosphate-buffered saline (PBS), centrifuged as described above and re-suspended to a sperm concentration of 20 × 10 6 / ml. One milliliter of this solution was centrifuged for 5 min at 300g. The final pellet was then processed for cytometric and immunohistochemical analyses in both cohorts of subjects studied.
When specified, sperm fractionation was performed by swim-up technique as follows: 1 ml of each seminal sample was diluted 1:2 with Hank's medium and centrifuged for 10 min at 300g; the supernatant was discarded and an aliquot of 0.5 ml of Hank's medium was layered on the top of the pellet; spermatozoa were allowed to migrate for 30 min at 378C; and then, the supernatant was gently aspirated and processed for the study.
Antibodies
Rabbit polyclonal anti-human clusterin antibody (H-330, #sc-8354; Santa Cruz Biotechnology, Germany), reacting with clusterin a and b chains, was used. The specificity of this antibody was tested using SDS gel electrophoresis, and western blotting of total sperm proteins performed as previously described (Muciaccia et al., 2005) . The primary antibody (1:500) was detected using the horse-radish peroxidase (HRP)-conjugated rabbit anti-goat IgG (1:6000; #61-1620; Zymed Laboratories, USA) and the ECL-Plus chemiluminescent protein detection kit (Amersham Bioscience, Italy).
Cytometric analysis
Spermatozoa were fixed in 1% paraformaldehyde, washed twice and permeabilized on ice using 0.1% Triton X-100 in 0.1% sodium citrate as previously described (Muciaccia et al., 2010) . After washing, the spermatozoa were incubated for 30 min with anti-clusterin primary antibody (1:200 in 1% BSA/PBS), washed and then treated with phycoerythrin-conjugated secondary antibody (goat anti-rabbit-PE, 1:400; #sc-3739; Santa Cruz). Affinity-purified rabbit IgG (Jackson ImmunoResearch Laboratories, UK) alone was used at the same concentrations as a negative control.
For the detection of the sperm DNA fragmentation by the TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling) technique, aliquots of 1 × 10 6 spermatozoa were treated using the
In Situ Cell Death Detection Kit-Fluorescein (Roche, Italy), according to the manufacturer's instructions. Subsequently, the cells were immunolabeled with clusterin and run through a flow cytometer (Epics XL Beckman Coulter, USA) using an Argon 488 nm excitation laser. We acquired 5000 and 10000 events for each single and double reaction/ tube, respectively. The results are expressed as the percentage of the positive spermatozoa gated.
Immunocytochemistry

Fluorescence microscopy
Freshly isolated spermatozoa were spotted onto poly-lysine-coated slides, air dried, fixed in 2% paraformaldehyde on ice and blocked with 1 mol/l glycine (Sigma Aldrich, Italy). Cells were then permeabilized using 0.1% Triton X-100 in 0.1% sodium citrate and washed. To double-stain sperm for TUNEL and clusterin, modifications were made to the antibody time exposure (1 h) and the primary antibody concentration (1:500). The secondary antibody was a donkey Cy3-conjugated anti-rabbit IgG, 1:300 (Jackson ImmunoResearch, UK). Negative controls were performed by omitting the primary antibodies and incubating with donkey Cy3-conjugated rabbit IgG (1:500). Nuclei were stained using TOTO3 (1:2000; Molecular Probes Invitrogen Corporation, Italy) for confocal microscopy observations.
Light microscopy
Slide-spotted spermatozoa from each of the subjects studied were fixed in cold acetone, air dried and processed for clusterin antigen immunocytochemical detection (using 1:100 for the primary antibody dilution). After washing, the avidin -biotin peroxidase complex (UltraTek HRP AntiPolyvalent kit; ScyTek Laboratories, USA) detection kit was used according to the manufacturer's instructions. The peroxidase activity was revealed using 3,3-diaminobenzidine tetrahydrochloride (Roche, Italy).
Statistical analysis
Descriptive analysis was performed for all variables and means, standard deviations, medians and skewness and kurtosis indexes were computed in the normotensive and hypertensive groups.
Comparisons between group means were performed by the Student t-test and/or Mann -Whitney tests when far from normality. The association of the continuous variables was assessed by multiple regression analyses and correlation coefficients. These analyses were performed separately for the two groups. For all tests and procedures, a value of P , 0.05 was considered significant.
Results
Seminal parameters
Mean, standard deviation, median and range of routine seminal parameters of all the subjects studied are reported in Table I . All subjects of control group presented a normal semen phenotype, whereas in the hypertensive subjects seminal parameters were within the normal range except a significant reduction in the forward motility (P , 0.01). Sperm vitality was within the normal range, i.e. ≥70% (World Health Organization, 1999) in the normotensive group, whereas in the hypertensive subjects, although the mean value was close to 70%, for a few subjects the value was below this cut-point (Table I) .
Clusterin cytometric analysis standardization
In all the normotensive subjects examined, using the polyclonal antihuman clusterin antibody H-330 which recognizes both a-and b-clusterin chains, the three different ranges of clusterin fluorescence were identified by flow cytometry as follows: M1, corresponding to nonfluorescent sperm; M2, corresponding to sperm with a medium fluorescence intensity mainly referable to intracellular clusterin and M3, corresponding to highly fluorescent sperm (Fig. 1A) . M1 represented the region of the non-specific binding with the isotype antibody and of spermatozoa not expressing clusterin (including reacted spermatozoa). M2 corresponded to the normal sperm population, which displayed clusterin labeling on the anterior region of the head ( Fig. 1C and D). M3 represented the group of altered spermatozoa, which displayed extensive clusterin labeling in the head and the tail both inside and on the surface of the spermatozoa (Fig. 1C) . FACS analysis and immunocytochemistry for clusterin before and after the swim-up selection, performed in three normal subjects, confirmed that the M3 region contained altered spermatozoa. When the spermatozoa were selected for their kinetic properties by the swim-up technique, the M3 region of the flow cytometric histograms was no longer evident (Fig. 1B) , the immunolabeling showed only normal spermatozoa (Fig. 1D) and, as expected, TUNEL positivity appeared strongly reduced (Fig. 1E and F, M4 region) .
FACS Clusterin and TUNEL analysis
The next step was to compare FACS and TUNEL analyses for the spermatozoa obtained from control (normotensive) and hypertensive donors ( Fig. 2 and Table II ). The two groups displayed significant differences in the mean fluorescence values of the two clusterin-positive sperm subpopulations, M2 and M3, obtained by FACS and in the TUNEL assay ( Fig. 2A and B) . Highly significant differences (t-test) of clusterin values and TUNEL positivity, expressed as % gated, in the control and hypertensive subjects is shown (Fig. 2C and Table II ). In the control group, the results from the FACS analysis revealed that the M2 mean value was 74.9 + 6.4 and M3 mean value was 15.3 + 4.5, whereas TUNEL assay gave a mean value of 13.4 + 4.7 (Fig. 2C) . In the hypertensive group, the results from the FACS analysis indicated that the M2 mean value was 55.3 + 12.3 and that the M3 mean value was 30.9 + 13.0, with a TUNEL assay value of 26.0 + 9.5 (Fig. 2C) . The mean values of the TUNEL-clusterin-M3 doublepositive spermatozoa (TUNEL/Cl) were 8.1 + 4.2 in the control group and 18.4 + 9.2 in the hypertensive group (Fig. 2C) .
A highly significant correlation (P , 0.01) between the M3 clusterin values and DNA sperm fragmentation was observed in the hypertensive subjects, which was not observed in the normotensive subjects (Table III) . Although the age range of the two groups was very large, with several hypertensive subjects over 50 years, i.e. the upper age limit of the control group, on the basis of descriptive statistical analysis performed, age was not correlated with M3 clusterin values in both groups. This was confirmed by multiple regression analyses that showed no significant correlation between the sperm M3 clusterin values and the age in both control and hypertensive groups (Table III) .
The lower vital sperm percentage observed in the hypertensive subjects (Table I) , induced us to verify whether high values of M3 clusterin and DNA sperm fragmentation could be explained by the presence of more dead sperm in the semen. By performing multiple regression analyses of M3 (dependant variable) and age, TUNEL and sperm cell mortality (predictive variables), we obtained that, in the hypertensive group M3 was significantly associated with TUNEL (P ¼ 0.01), but not with cell mortality (P ¼ 0.59). M3 was instead associated with cell mortality (P ¼ 0.06) only in the normotensive group (Table IV) . As expected (Singh et al., 2003) , TUNEL was correlated with age in the normotensive group (r ¼ 0.72). However, in the hypertensive subjects TUNEL was not correlated with age (r ¼ 0.34), nor with sperm cell mortality (r ¼ 0.16; Table III ).
Light and confocal microscopy
The morphology of clusterin-positive spermatozoa has been studied by light (Fig. 1C and D ) and confocal microscopy ( Fig. 3) . As previously reported (O'Bryan et al., 1994b) , immunocytochemical labeling of clusterin, highlighted four classes of spermatozoa with different staining distribution patterns: cells highly labeled in the head and/or in the flagellum, cells labeled only in the acrosomal region, cells weakly labeled only in the equatorial segment and unlabeled cells. The fluorescence confocal microscopic analysis (Fig. 3) identifies single immunolabeled (clusterin-or TUNEL-positive) spermatozoa and double immunolabeled (clusterin-and TUNEL positive) spermatozoa, in the same region (merging fluorescence) or in different regions (i.e. nucleus and flagellum). Serial images acquired along the z-plane allowed us to identify abnormal spermatozoa with intranuclear clusterin immunostaining (not shown).
Discussion
In the present study, we have analyzed semen samples from both normotensive and hypertensive subjects not affected by other comorbid conditions. Although the small size of the cohorts studied, we report a lower sperm quality in the hypertensive subjects. Standard seminal examination did not highlight significant differences between samples from the normotensive and hypertensive subjects, with the exception of a reduced forward motility and vitality. Sperm samples were assayed by clusterin immunolabeling, as qualitative sperm marker to detect morphologically abnormal spermatozoa, and by the TUNEL technique to evaluate the presence of DNA fragmentation in the sperm. Our results demonstrate that the amount of the spermatozoa from hypertensive subjects with high clusterin immunolabeling and DNA damage was twice or even more than observed in the normotensive subjects. The observed increased mean values were statistically significant (P , 0.01). As demonstrated by multiple regression analyses, M3 values were not related to age nor to the amount of dead spermatozoa. Thus, in the hypertensive group, M3 identifies a novel subset of morphologically altered spermatozoa, not necessarily dead, which display extensive clusterin labeling in the head and the tail both inside and/or on the surface of the spermatozoa. The vast majority of M3-positive sperm cell subset carried fragmented DNA, as revealed by their TUNEL positivity in both cytometric and immunofluorescent analyses. However, TUNEL values did not correlate with those of sperm cell mortality, thus suggesting that the observed increase in sperm double-stranded DNA breaks does not necessarily result from sperm cell apoptotic events. It is well known that physical architecture of spermatozoa prevents the apoptotic process and that DNA damage observed in human spermatozoa is mostly to be related to oxidative stress (Aitken and De Iuliis, 2010) . (A and B) . By immunocytochemistry, normal spermatozoa labeled in the acrosomal region only, possibly corresponding to the flow cytometry M2 region (large dotted square), were observed in the total sperm population, together with morphological abnormal spermatozoa with highly clusterin labeled head and flagellum, possibly corresponding to the M3 region of flow cytometry (small dotted square) (C). Highly labeled cells were not present after swim-up selection of motile spermatozoa (D). Swim-up selection drastically reduces also the amount of TUNEL-positive spermatozoa (E and F) as indicated by the low number of events revealed in the M4 region by flow cytometry. In the upper central insert, a western blot confirming the molecular weight of sperm clusterin bands specifically recognized by the primary antibody used, is visible. Bands at 80 kDa represent the heterodimeric form of the protein, while the single chains migrate at 40 kDa.
As for the normotensive healthy control subjects, cytometric M3 clusterin values labeled a small fraction of the whole semen containing altered spermatozoa, nearly correlating with sperm cell death (P ¼ 0.06), but not with TUNEL. In addition, in these subjects no significant correlation was observed between TUNEL and sperm cell mortality, thus confirming that TUNEL positivity reveals DNA damage not necessarily associated with cell death.
The possibility that sperm damage revealed by FACS clusterin and TUNEL detection is to be related to the anti-hypertensive drug therapy has been carefully evaluated. Some anti-hypertensive pharmacological agents are currently thought to be responsible for male impotence and/or to have effects on several phases of the sexual response (Düsing, 2005) . Decreased sperm motility has been reported to be induced by angiotensin II (AII) receptor antagonists (Vinson et al., 1995) . By interfering with the intra-sperm calcium concentration, calcium channel blockers may affect calcium-dependent events such as the regulation of sperm motility, chemotaxis and capacitation (Lishko and Kirichok, 2010) . However, it has to be considered that most of the studies on the potential effects of calcium channel blockers on sperm functions have been performed in in vitro animal models (Kirkman-Brown et al., 2003; Feng et al., 2007) . In conclusion, to our knowledge adverse effects of anti-hypertensive drug therapy on sperm morphology in vivo have not been reported in the literature.
To further confirm, for each of the antihypertensive drugs used, adverse effects on male reproductive system and semen quality, have been evaluated by examining: (i) the drug data sheet on the Italian drug regulatory agency website (http://www.agenziafarmaco .gov.it/it) and (ii) evidence-based information from Micromedexw2, a post-marketing surveillance database that considers published specific literature, including unbiased referenced information concerning drug side effects, drugs interactions and contraindications (http:// www.thomsonhc.com/micromedex2/librarian/). None of these database provided additional information.
The poor semen quality observed in the hypertensive subjects is reasonably related to the high BP. The blood pressure variability during 24 h is a hydrodynamic characteristic of normotensive as well as hypertensive subjects undergoing therapy (Kaplan and Victor, 2010) . Therefore in the latter group, although BP is within normal ranges at the time of spot checks, cellular and parenchyma damages consequent to high BP may occur. Moreover, it cannot be excluded that antihypertensive treatments were started well after the onset of the pathology.
Metabolic disorders are known to compromise male fertility and the poor sperm quality frequently observed in these pathologic conditions has been generally explained by the enhanced oxidative stress due to the excessive production of reactive oxygen species and limited antioxidant defense (Sharma et al., 1999; Brownlee 2005; Amaral et al., 2008) . Recently, evidence has been produced demonstrating an increase in EPC in the ejaculated spermatozoa from subjects affected by metabolic disorders such as type-1-and type-2-diabetic and non-diabetic obesity. Comparative proteomic studies indicated an increased concentration in EPC components semenogelin-1, clusterin and lactotransferrin in the sperm proteomes of the above disease groups (Paasch et al., 2011) . In addition, DNA fragmentation has been observed to be increased in all three groups of pathological samples. It has been proposed that the accumulation of degradation products of clusterin and of other components of the EPC as a consequence of the mentioned metabolic disorders compromises the protective activity and regulatory functions of the protein network, thus impairing vital sperm functions and particularly motility (Paasch et al., 2011) . In our pilot study the observed higher clusterin immunolabeling and DNA fragmentation in the ejaculated spermatozoa of hypertensive men compared with controls, together with the reduction in sperm forward motility and vitality, move in the same direction.
It is well known that hypertension induces a general altered vascular status and an enhanced ROS generation which is not counterbalanced by the endogenous antioxidant mechanisms, thus leading to a state of oxidative stress (Schulz et al., 2011) . Although the production of ROS by spermatozoa is a physiological process (Vernet et al., 2004) , an imbalance between generation and scavenging of ROS may lead to DNA alterations (Aitken and Fisher, 1994) , especially during sperm transport through the epididymis (Vernet et al., 2004; Ollero et al., 2001 Spermatozoa are indeed particularly susceptible to peroxidative damage, since most of their cytoplasm is removed during the final stages of spermiogenesis, resulting in the loss of important defensive enzymes (among which catalase, glutathione peroxidase) which are involved in the protection from ROS attacks (Ebisch et al., 2007) . In addition, sperm plasma membrane, displaying fusogenic properties, is particularly rich in polyunsaturated fatty acids resulting in very high sperm susceptibility to lipid peroxidation from ROS attacks (Jones and Mann, 1973) . As it has been claimed to occur in metabolic disorders (Paasch et al., 2011) , the observed high percentage of heavily clusterin immunolabeled spermatozoa could reflect an adequate cellular response aiming at the prevention of lipid -protein peroxidation and DNA fragmentation.
To our knowledge, this is the first time that the presence of the clusterin antigen on human ejaculated spermatozoa using both cytometric and immunofluorescence analysis has been extensively described. Our data suggest that a high level of clusterin immunolabeling, which corresponds to the M3 clusterin value evident in the FACS analysis, identifies a distinct fraction of spermatozoa that carry strong morphological alterations often associated with DNA fragmentation.
Both the cytometric and the immunofluorescence analyses of samples double labeled for clusterin and TUNEL positivity allow one to identify five different patterns of sperm staining: (i) normal clusterin-immunolabeling and TUNEL negativity, identifying normal cells; (ii) high level of clusterin labeling associated with TUNEL negativity possibly identifying spermatozoa with intact DNA but with morphological alterations; (iii) TUNEL positivity associated with normal clusterin labeling identifying normal-shaped spermatozoa with fragmented DNA; (iv) TUNEL spermatozoa displaying nuclear clusterin staining at confocal microscopy, possibly identifying apoptotic cells. In other cellular types, nuclear clusterin is indeed considered an apoptotic marker (Leskov et al., 2003; Kim et al., 2011) ; (v) TUNELpositive spermatozoa with high clusterin labeling, identifying a sperm cell population with altered morphology and fragmented DNA. The latter is the sperm population that we observed to be significantly increased in the hypertensive subjects.
In proteomic studies (Martínez-Heredia et al., 2008) , clusterin precursors have been detected at a higher amount in asthenozoospermic samples. Moreover, recently in proteomic studies carried out on fertile stallions, clusterin was identified as one of the potential biomarker proteins of semen quality and fertility (Novak et al., 2010) . The accumulation of surface clusterin in abnormal spermatozoa may be an indication of unfavorable testicular conditions or germ cell aberrations that might affect fertility, though undetectable by routine examinations.
The observed relationships between hypertension and altered semen markers represent a novel and possibly relevant information to be considered in the study of male fertility, easily detectable by a non-invasive assessment. Finally, further studies based on a large number of subjects undergoing different anti-hypertensive therapy could unveil whether drugs reducing the oxidative stress, such as sartans, which are active through the inhibition of angiotensin receptor II, are the most adequate to preserve sperm quality.
